Advertisement

Headaches of the Elderly

  • Thomas P. Bravo
Headache (RB Halker, Section Editor)
Part of the following topical collections:
  1. Topical Collection on Headache

Abstract

The prevalence of headache decreases in elderly age groups; however, headache remains a significant issue with unique diagnostic and therapeutic considerations in this population. While primary headache disorders such as migraine and tension-type headache still occur in the majority of cases, secondary headaches are more common with advancing age. Additionally, several rare primary headache disorders, such as hypnic headache and primary cough headache, occur more frequently in an elderly population and have distinct treatments. In this review, we provide an updated overview of the common, concerning, and unique headache disorders affecting the elderly.

Keywords

Headache Elderly Geriatric Migraine Aura without headache Hypnic headache Primary cough headache Sleep apnea headache Giant cell arteritis Cardiac cephalalgia Subacute glaucoma Medication overuse headache Trigeminal neuralgia Post-herpetic trigeminal neuropathy 

Notes

Compliance with Ethics Guidelines

Conflict of Interest

Thomas P. Bravo declares that he has no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Stovner LJ, Hagen K, Jensen R, et al. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia. 2007;27:193–210.CrossRefPubMedGoogle Scholar
  2. 2.
    Cook N, Evans DA, Funkenstein H, et al. Correlates of headache in a population-based cohort of elderly. Archives of Neurology. 1989;46:1338–44.CrossRefPubMedGoogle Scholar
  3. 3.
    Prencipe M, Casini AR, Ferretti C, Santini M, Pezzella F, Scaldaferri N, et al. Prevalence of headache in an elderly population: attack frequency, disability, and use of medication. J Neurol Neurosurg Psychiatry. 2001;70:377–81.CrossRefPubMedCentralPubMedGoogle Scholar
  4. 4.•
    Ruiz M, Pedraza MI, de la Cruz C, et al. Headache in the elderly: a series of 262 patients. Neurologia. 2014;29:321–6. A large retrospective review of elderly patients presenting for tertiary headache evaluation. Ruiz et al. provide epidemiologic data for prevalence of different headache disorders at advanced ages; an area not well studied in the current literature.CrossRefPubMedGoogle Scholar
  5. 5.
    Fuh JL, Wang SL, Lu SR, et al. A 13 year long-term outcome study of elderly chronic daily headache. Cephalagia. 2008;28:1017–22.CrossRefGoogle Scholar
  6. 6.
    Solomon G, Kunkel R, Frame J. Demographics of headache in elderly patients. Headache. 1990;30:273–6.CrossRefPubMedGoogle Scholar
  7. 7.
    Pasqual J, Berciano J. Experience in the diagnosis of headaches that start in elderly people. Journal of Neurology, Neurosurgery and Psychiatry. 1994;57:1255–7.CrossRefGoogle Scholar
  8. 8.
    “Definition of an older or elderly person.” World Health Organization. Web. 15 Feb. 2015. <http://www.who.int/healthinfo/survey/ageingdefnolder/en>.
  9. 9.
    Rasmussen BK, Lipton RB. Prognosis of migraines. In: Olesen J, Goadsby PJ, Ramadan NM, Tfelt-Hansen P, Welch KMA, editors. The headaches. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2006. p. 429–31.Google Scholar
  10. 10.
    Victor TW, Hu X, Campbell JC, et al. Migraine prevalence by age and sex in the United States: a life-span study. Cephalalgia. 2010;30:1065–72.CrossRefPubMedGoogle Scholar
  11. 11.
    Haan J, Hollander J, Ferrari MD. Migraine in the elderly: a review. Cephalalgia. 2007;27:91–106.CrossRefGoogle Scholar
  12. 12.
    Rasmussen BK, Olesen J. Migraine with aura and migraine without aura: an epidemiological study. Cephalalgia. 1992;12:221–8.CrossRefPubMedGoogle Scholar
  13. 13.
    Martins KM, Bordini CA, Bigal ME, et al. Migraine in the elderly: a comparison with migraine in young adults. Headache. 2006;46:312–6.CrossRefPubMedGoogle Scholar
  14. 14.
    Kelman L. Migraine changes with age: IMPACT on migraine classification. Headache. 2006;46:1161–71.CrossRefPubMedGoogle Scholar
  15. 15.
    Landy SH, Lobo BL. Migraine treatment throughout the lifecycle. Expert Rev Neurotherapeutics. 2005;5:343–53.CrossRefGoogle Scholar
  16. 16.
    Dodick D, Lipton RB, Martin V, et al. Consensus statement: cardiovascular safety profile of triptans (5-HT1B/1D agonists) in the acute treatment of migraine. Headache. 2004;44:414–25.CrossRefPubMedGoogle Scholar
  17. 17.•
    Roberto G, Raschi E, Piccinni C, et al. Adverse cardiovascular events associated with triptans and ergotamines for treatment of migraine: systematic review of observational studies. Cephalgia. 2015;35:118–31. A thorough systematic review of the literature regarding the cardiovascular safety of vasoactive substances for treatment of headache that provides strong, although not definitive, evidence that triptans are safe in patients without preexisting cardiovascular disease.CrossRefGoogle Scholar
  18. 18.••
    Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013;33:629–808. This is the current standard for the classification of headache disorder, currently in a beta version.Google Scholar
  19. 19.
    Fisher CM. Late-life migraine accompaniments as a cause of unexplained transient ischemic attacks. Can J Neurol Sci. 1980;7:9–17.PubMedGoogle Scholar
  20. 20.
    Fisher CM. Late-life migraine accompaniments—further experience. Stroke. 1986;17:1033–42.CrossRefPubMedGoogle Scholar
  21. 21.
    Bamford CC, Mays M, Stewart SJ. Unusual headaches in the elderly. Curr Pain Headache. 2011;15:295–301.CrossRefGoogle Scholar
  22. 22.
    Donnet A, Daniel C, Milandre L, et al. Migraine with aura in patients over 50 years of age: the Marseille’s registry. J Neurol. 2012;259:1868–73.CrossRefPubMedGoogle Scholar
  23. 23.
    Kleinig TJ, Kiley M, Thompson PD. Acute convexity subarachnoid haemorrhage: a cause of aura-like symptoms in the elderly. Cephalalgia. 2008;28:658–63.CrossRefPubMedGoogle Scholar
  24. 24.
    Izenberg A, Aviv RI, Demaerschalk BM, et al. Crescendo transient aura attacks: a transient ischemic attack mimic caused by focal subarachnoid hemorrhage. Stroke. 2009;40:3725–9.CrossRefPubMedGoogle Scholar
  25. 25.•
    Vongvaivanich K, Lertakyamanee P, Silberstein SD, et al. Late-life migraine accompaniments: a narrative review. Cephalalgia. 2014; [Epub ahead of print]. A current comprehensive literature review of late-life migraine accompaniments and potential secondary causes.Google Scholar
  26. 26.•
    Holle D, Naegel S, Obermann M. Hypnic headache. Cephalalgia. 2013;33:1349–57. A comprehensive review of hypnic headache that includes a review of prior studies on clinical characteristics that contributed to a change to the diagnostic criteria.CrossRefPubMedGoogle Scholar
  27. 27.
    Liang JF, Wang SJ. Hypnic headache: a review of clinical features, therapeutic options and outcomes. Cephalalgia. 2014;34:795–805.CrossRefPubMedGoogle Scholar
  28. 28.
    Boes CJ, Matharu MS, Goadsby PJ. Benign cough headache. Cephalalgia. 2002;22:772–9.CrossRefPubMedGoogle Scholar
  29. 29.
    Chen PK, Fuh JL, Wang SJ. Cough headache: a study of 83 consecutive patients. Cephalalgia. 2009;29:1079–85.CrossRefPubMedGoogle Scholar
  30. 30.
    Cordenier A, De Hertogh W, De Keyser J, et al. Headache associated with cough: a review. J Headache Pain. 2013;14:42.CrossRefPubMedCentralPubMedGoogle Scholar
  31. 31.
    Duran J, Esnaola S, Rubio R, et al. Obstructive sleep apnea–hypopnea and related clinical features in a population-based sample of subjects aged 30 to 70 yr. Am J Respir Crit Care Med. 2001;163:685–9.CrossRefPubMedGoogle Scholar
  32. 32.•
    Kristiansen HA, Kværner KJ, Akre H, et al. Sleep apnoea headache in the general population. Cephalalgia. 2012;32:451–8. A large population study on sleep apnea headache that provides evidence that there may not be a direct relationship between hypoxia and occurrence of headache.CrossRefPubMedGoogle Scholar
  33. 33.
    Russell MB, Kristiansen HA, Kværner KJ. Headache in sleep apnea syndrome: epidemiology and pathophysiology. Cephalalgia. 2014;43:752–5.CrossRefGoogle Scholar
  34. 34.
    Goksan B, Gunduz A, Karadeniz D, et al. Morning headache in sleep apnoea: clinical and polysomnographic evaluation and response to nasal continuous positive airway pressure. Cephalalgia. 2009;29:635–41.CrossRefPubMedGoogle Scholar
  35. 35.
    Caselli RJ, Hunder GG, Whisnant JP. Neurologic disease in biopsy-proven giant cell (temporal) arteritis. Neurology. 1988;38:352–9.CrossRefPubMedGoogle Scholar
  36. 36.
    Smith JH, Swanson JW. Giant cell arteritis. Headache. 2014;54:1273–89.CrossRefPubMedGoogle Scholar
  37. 37.
    Huston KA, Hunder GG, Lie JT. Temporal arteritis: a 25-year epidemiologic, clinical, and pathologic study. Annals of Internal Medicine. 1978;88:162–7.CrossRefPubMedGoogle Scholar
  38. 38.
    Myklebust G, Gran JT. A prospective study of 287 patients with polymyalgia rheumatica and temporal arteritis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis. Br J Rheumatol. 1996;35:1161–8.CrossRefPubMedGoogle Scholar
  39. 39.
    Hunder GG, Bloch DA, Michel BA, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum. 1990;33:1122–8.CrossRefPubMedGoogle Scholar
  40. 40.
    Grayson PC, Tomasson G, Cuthbertson D, et al. Association of vascular physical examination findings and arteriographic lesions in large vessel vasculitis. J Rheumatol. 2012;39:303–9.CrossRefPubMedCentralPubMedGoogle Scholar
  41. 41.
    Arida A, Kyprianou M, Kanakis M, Sfikakis PP. The diagnostic value of ultrasonography-derived edema of the temporal artery wall in giant cell arteritis: a second meta-analysis. BMC Musculoskelet Disord. 2010;11:44.CrossRefPubMedCentralPubMedGoogle Scholar
  42. 42.
    Klink T, Geiger J, Both M, et al. Giant cell arteritis: diagnostic accuracy of MR imaging of superficial cranial arteries in initial diagnosis-results from a multicenter trial. Radiology. 2014;273:844–52.CrossRefPubMedGoogle Scholar
  43. 43.
    Mukhtyar C, Guillevin L, Cid MC, et al. EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis. 2009;68:318–23.CrossRefPubMedGoogle Scholar
  44. 44.
    Bini A, Evangelista A, Castellini P, et al. Cardiac cephalgia. J Headache Pain. 2009;10:3–9.CrossRefPubMedCentralPubMedGoogle Scholar
  45. 45.
    Wei JH, Wang HF. Cardiac cephalalgia: case reports and review. Cephalalgia. 2008;28:892–6.CrossRefPubMedGoogle Scholar
  46. 46.
    Grace A, Horgan J, Breathnach K, et al. Anginal headache and its basis. Cephalalgia. 1997;17:195–6.CrossRefPubMedGoogle Scholar
  47. 47.
    Ohringer G, Burke T, Shaikh A. Unilateral headache and loss of vision. BMJ. 2014;348:1188.CrossRefGoogle Scholar
  48. 48.
    Ritch R, Lowe RF. Angle-closure glaucoma: clinical types. In: Ritch R, Shields MB, Krupin T, editors. The glaucomas. St. Louis: Mosby-Year Book; 1996. p. 821–40.Google Scholar
  49. 49.
    Nesher R, Epstein E, Stern Y, et al. Headaches as the main presenting symptom of subacute angle closure glaucoma. Headache. 2005;45:166–76.CrossRefGoogle Scholar
  50. 50.
    Shindler KS, Sankar PS, Vlpe NJ, et al. Intermittent headaches as the presenting sign of subacute angle closure glaucoma. Neurology. 2005;65:757–8.CrossRefPubMedGoogle Scholar
  51. 51.•
    Westergaard ML, Hansen EH, Glumer C, et al. Definitions of medication-overuse headache in population-based studies and their implications on prevalence estimates: a systematic review. Cephalalgia. 2014;34:409–25. An extensive review of the varied prior definitions of medication overuse headache and the overall prevalence among different groups.CrossRefPubMedGoogle Scholar
  52. 52.
    Prencipe M, Casini AR, Feretti C, et al. Prevalence of headache in an elderly population: attack frequency, disability, and use of medication. J Neurol Neurosurg Psychiatry. 2001;70:377–81.CrossRefPubMedCentralPubMedGoogle Scholar
  53. 53.
    Wang SJ, Fuh JL, Lu SR, et al. Chronic daily headache in Chinese elderly prevalence, risk factors, and biannual follow-up. Neurology. 2000;54:314–9.CrossRefPubMedGoogle Scholar
  54. 54.
    Zeeberg P, Olesen J, Jensen R. Probable medication-overuse headache: the effect of a 2-month drug-free period. Neurology. 2006;66:1894–8.CrossRefPubMedGoogle Scholar
  55. 55.
    Dodick DW. Pearls: headache. Seminars in Neurology. 2010;30:74–81.CrossRefPubMedGoogle Scholar
  56. 56.•
    Lynch KM, Brett F. Headaches that kill: a retrospective study of incidence, etiology and clinical features in cases of sudden death. Cephalalgia. 2012;32:972–8. A retrospective study of fatal cases presenting with headache that demonstrate concerning ‘red flags’ for serious secondary causes.CrossRefPubMedGoogle Scholar
  57. 57.
    Sjaastad O, Bakketeig LS. Prevalence of cervicogenic headache: Vågå study of headache epidemiology. Acta Neurol Scand. 2008;117:173–80.CrossRefPubMedGoogle Scholar
  58. 58.
    Rozen TD, Capobianco DJ, Dalessio DJ. Cranial neuralgias and atypical facial pain. In: Silberstein SD, Lipton RB, Dalessio DJ, editors. Wolff’s headache and other head pain. 7th ed. New York: Oxford University Press; 2001. p. 509–24.Google Scholar
  59. 59.•
    Maarbjerg S, Gozalov A, Olesen J, et al. Trigeminal neuralgia—a prospective systematic study of clinical characteristics in 158 patients. Headache. 2014;54:1574–82. A large prospective study of the clinical characteristics of TN which had the notable findings of a high percentage of persistent facial pain, cranial autonomic symptoms and bedside sensory abnormalities.CrossRefPubMedGoogle Scholar
  60. 60.
    Maarbjerg S, Wolfram F, Gozalov A, et al. Significance of neurovascular contact in classical trigeminal neuralgia. Brain. 2015;138:311–9.CrossRefPubMedGoogle Scholar
  61. 61.
    Gronseth G, Cruccu G, Alksne J, et al. Practice parameter: the diagnostic evaluation and treatment of trigeminal neuralgia (an evidence-based review). Neurology. 2008;71:1183–90.CrossRefPubMedGoogle Scholar
  62. 62.
    Wu CJ, Lian YJ, Zheng YK, et al. Botulinum toxin type A for the treatment of trigeminal neuralgia: results from a randomized, double-blind, placebo-controlled trial. Cephalalgia. 2012;32:443–60.CrossRefPubMedGoogle Scholar
  63. 63.
    Harpaz R, Ortega-Sanchez IR, Seward JF, Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2008;57(RR-5):1.PubMedGoogle Scholar
  64. 64.
    Carbone V, Leonardi A, Pavese M, et al. Herpes zoster of the trigeminal nerve: a case report and review of the literature. Minerva Stomatol. 2004;53(1–2):49–59.PubMedGoogle Scholar
  65. 65.
    Moller L. Aspects of the natural history of herpes zoster. Acta Derm Venereol. 1969;49:569–83.Google Scholar
  66. 66.
    Oxman MN, Levin MJ, Johnson GR, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005;352(22):2271.CrossRefPubMedGoogle Scholar
  67. 67.
    Wood MJ, Kay R, Dworkin RH, et al. Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: a meta-analysis of placebo-controlled trials. Clin Infect Dis. 1996;22:341–7.CrossRefPubMedGoogle Scholar
  68. 68.
    Johnson RW, Rice ASC. Postherpetic neuralgia. N Engl J Med. 2014;371:1526–33.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  1. 1.Department of NeurologyMayo ClinicPhoenixUSA

Personalised recommendations